PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
Condition: Prostate Cancer
Study Type: Observational [Patient Registry]
Clinical Trials Identifier NCT 8-digits: NCT04995198
Sponsor: Prostate Cancer Clinical Trials Consortium
Phase:
Eligibility:
- Age: minimum 18 Years maximum N/A
- Gender: Male
Inclusion Criteria:
- Have prostate cancer (any stage of disease or survivorship) diagnosed or documented through one of the following:
- tissue biopsy, and/or
- PSA greater than 100 ng/dL (1ng/ml), and/or
- clear radiographic evidence of disease
- Live in the United States (including Puerto Rico, Guam, American Samoa, US Virgin Islands, Northern Mariana Islands)
Exclusion Criteria:
- Unable or unwilling to provide all of the necessary information for eligibility
- Incomplete inclusion criteria
View trial on ClinicalTrials.gov
{{footer-clinical-trials-navigation}}